Medline Inc.
L10
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/28/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.55B | 27.55B | 26.82B | 26.12B | 25.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.55B | 27.55B | 26.82B | 26.12B | 25.52B |
| Cost of Revenue | 20.99B | 20.05B | 19.45B | 18.99B | 18.57B |
| Gross Profit | 7.56B | 7.50B | 7.38B | 7.13B | 6.95B |
| SG&A Expenses | 4.56B | 4.46B | 4.33B | 4.22B | 4.11B |
| Depreciation & Amortization | 704.50M | 705.50M | 701.50M | 693.50M | 685.50M |
| Other Operating Expenses | 67.00M | 53.00M | 67.00M | 55.00M | 38.50M |
| Total Operating Expenses | 26.33B | 25.27B | 24.55B | 23.96B | 23.40B |
| Operating Income | 2.23B | 2.28B | 2.28B | 2.17B | 2.12B |
| Income Before Tax | 1.26B | 1.36B | 1.35B | 1.29B | 1.24B |
| Income Tax Expenses | 96.00M | 86.00M | 77.00M | 59.00M | 46.00M |
| Earnings from Continuing Operations | 1.16K | 1.27K | 1.27K | 1.23K | 1.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00M | -- | -- | -- | -- |
| Net Income | 1.16B | 1.27B | 1.27B | 1.23B | 1.20B |
| EBIT | 2.23B | 2.28B | 2.28B | 2.17B | 2.12B |
| EBITDA | 3.24B | 3.28B | 3.28B | 3.15B | 3.10B |
| EPS Basic | 0.28 | 0.07 | 0.05 | 0.03 | 0.02 |
| Normalized Basic EPS | 0.24 | 0.04 | 0.02 | 0.01 | 0.01 |
| EPS Diluted | 0.28 | 0.07 | 0.05 | 0.03 | 0.02 |
| Normalized Diluted EPS | 0.24 | 0.04 | 0.02 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 35.79B | 52.45B | 34.97B | 17.47B | 17.47B |
| Average Diluted Shares Outstanding | 53.26B | 69.92B | 52.44B | 34.93B | 17.47B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 44.48% | 140.07% | 133.80% | 130.71% | 126.66% |